In this article, Chen et al. show that a chemical modification of transfer RNA, along its corresponding RNA modifier enzyme, is diminished in acute myeloid leukaemia. These findings further support the role of an aberrant epitranscriptome in haematological malignancies. Commentary on: Chen et al. Hydroxy-wybutosine tRNA modifications as indicators of disease progression and therapeutic targets in leukemia. Br J Haematol 2024 (Online ahead of print). doi: 10.1111/bjh.19873.
Rongliang Wang, Babak Mehrjou, Dorsa Dehghan‐Banian, Belle Yu Hsuan Wang, Qiangqiang Li, Shuai Deng, Chuanhai Liu, Zhe Zhang, Yanlun Zhu, Haixing Wang, Dan Li, Xiaomin Lu, Jack C. Y. Cheng, Michael Tim‐Yun Ong, Hon Fai Chan, Paul Kim Ho Chu, Wayne Lee
Roos van Westrhenen, Allan H. Young, Urs Heilbronner, Mário F. Juruena, Magnus Ingelman‐Sundberg, Marin M. Jukić, Jaakko Kaprio, Martien J. Kas, Ramona Moldovan, Markus M. Nöthen, Alexandra Philipsen, Noam Shomron, Erik Van der Eycken, Eduard Vieta, Thomas G. Schulze
Discussion(0)
No comments yet. Be the first to comment.